Therefore, and due to our MR results indicating a possible protective effect on CKD, we examined the association between galectin-1 and eGFR among individuals with newly diagnosed type 2 diabetes in the ANDIS cohort, particularly those with SIRD previously reported to have increased risk of diabetic kidney disease [3]. Here, LGALS1 is linked to type 2 diabetes mellitus.